Barclays analyst Adrienne Yih raised the firm’s price target on National Vision (EYE) to $38 from $32 and keeps an Overweight rating on the shares post the Q4 beat. The company’s “structural improvements” are driving sales and earnings power, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYE:
- National Vision (EYE): Buy Rating on Strong Comp Growth, Premium Mix Shift, and AI-Enabled Eyewear Upside
- National Vision price target raised to $40 from $35 at Citi
- National Vision: Solid Execution and Strategic Momentum Offset by Traffic Headwinds and Full Valuation, Justifying Hold Rating
- Morning Movers: Moderna rises after entering COVID settlement agreement
- National Vision: Strategic Mix Shift and Margin Expansion Support Buy Rating Despite Near-Term Traffic Headwinds